Db 03 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Experts introduce the antibody-drug conjugates (ADCs) trastuzumab emtansine (T-DM1) and trastuzumab deruxtecan (T-DXd) and discuss clinical trial findings and potential use in special patient populations, such as those with brain metastases.

Sara hurvitzMelindal telliHeather mcarthurBreast cancerHer2 breast cancerHer2 positive breast cancerMetastatic breast cancerSecond line therapyTrastuzumab deruxtecanTrastuzumab emtansineT dm1T dxdDestiny breast03Db 03Interstitial lung diseaseBlood brain barrier